4.63
Schlusskurs vom Vortag:
$4.59
Offen:
$4.55
24-Stunden-Volumen:
463.34K
Relative Volume:
0.60
Marktkapitalisierung:
$408.97M
Einnahmen:
$73.48M
Nettoeinkommen (Verlust:
$-108.30M
KGV:
-2.0578
EPS:
-2.25
Netto-Cashflow:
$-67.17M
1W Leistung:
-3.14%
1M Leistung:
+21.84%
6M Leistung:
+16.62%
1J Leistung:
+253.44%
Personalis Inc Stock (PSNL) Company Profile
Firmenname
Personalis Inc
Sektor
Branche
Telefon
650-752-1300
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Vergleichen Sie PSNL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PSNL
Personalis Inc
|
4.63 | 422.19M | 73.48M | -108.30M | -67.17M | -2.25 |
![]()
TMO
Thermo Fisher Scientific Inc
|
402.82 | 148.60B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.90 | 132.07B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
513.36 | 40.34B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
111.92 | 30.82B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
140.33 | 23.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-15 | Eingeleitet | Guggenheim | Buy |
2025-03-17 | Eingeleitet | Craig Hallum | Buy |
2023-02-06 | Hochstufung | Needham | Hold → Buy |
2022-01-07 | Hochstufung | BofA Securities | Neutral → Buy |
2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2021-11-03 | Herabstufung | Needham | Buy → Hold |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2021-09-20 | Bestätigt | Needham | Buy |
2021-05-06 | Hochstufung | Oppenheimer | Perform → Outperform |
2021-01-28 | Eingeleitet | Truist | Buy |
2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
2020-11-12 | Bestätigt | Needham | Buy |
2020-11-06 | Herabstufung | Oppenheimer | Outperform → Perform |
2020-10-19 | Eingeleitet | Citigroup | Buy |
2020-10-08 | Eingeleitet | BTIG Research | Buy |
2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
2020-08-18 | Eingeleitet | Needham | Buy |
2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
2019-07-15 | Eingeleitet | BofA/Merrill | Neutral |
2019-07-15 | Eingeleitet | Cowen | Outperform |
2019-07-15 | Eingeleitet | Morgan Stanley | Overweight |
2019-07-15 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Personalis Inc Aktie (PSNL) Neueste Nachrichten
Millennium Management LLC Has $7.61 Million Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
BNP Paribas Financial Markets Acquires 71,721 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World
Personalis and Academic Partners to Present Latest Data on Ultra - GuruFocus
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection - Yahoo Finance
Personalis Holds Virtual Annual Stockholders Meeting - TipRanks
PSNL to Discuss Future Plans in Upcoming Virtual Meeting | PSNL Stock News - GuruFocus
Brokerages Set Personalis, Inc. (NASDAQ:PSNL) PT at $8.00 - Defense World
Personalis Inc (PSNL): A Sitting Duck With -162.63% Upside Potential - Stocksregister
Guggenheim Begins Coverage on Personalis (NASDAQ:PSNL) - Defense World
Personalis, Inc. (NASDAQ:PSNL) Stake Raised by Jane Street Group LLC - Defense World
Jane Street Group LLC Has $2.32 Million Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - The AM Reporter
Personalis, Inc. (NASDAQ:PSNL) Shares Acquired by Stifel Financial Corp - Defense World
Guggenheim Initiates Buy Rating for Personalis (PSNL) with $6 Ta - GuruFocus
Guggenheim starts Personalis with a Buy, cites ‘best-in-class infrastructure’ - TipRanks
Guggenheim Initiates Buy Rating for Personalis (PSNL) with $6 Target | PSNL Stock News - GuruFocus
Guggenheim Initiates Personalis at Buy With $6 Price Target - marketscreener.com
Guggenheim Starts Coverage on Personalis (PSNL) with Buy Rating - GuruFocus
Guggenheim Starts Coverage on Personalis (PSNL) with Buy Rating | PSNL Stock News - GuruFocus
Dimensional Fund Advisors LP Purchases 242,141 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World
Raymond James Financial Inc. Takes Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Leading Genomics Company Personalis Takes Center Stage at Major Craig-Hallum Investor Conference - Stock Titan
Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference - Yahoo Finance
Personalis stock price target raised to $9 at H.C. Wainwright By Investing.com - Investing.com Nigeria
What is HC Wainwright’s Estimate for Personalis Q2 Earnings? - Defense World
Personalis reiterates 2025 revenue guidance of $80M-$90M with focus on MRD testing growth - MSN
HC Wainwright Raises Personalis (NASDAQ:PSNL) Price Target to $9.00 - Defense World
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates - MSN
Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth - Yahoo Finance
Barclays PLC Acquires 43,900 Shares of Personalis, Inc. (NASDAQ:PSNL) - The AM Reporter
JPMorgan Chase & Co. Has $34,000 Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Barclays PLC Increases Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Personalis stock price target raised to $9 at H.C. Wainwright - Investing.com Australia
Personalis Inc.: Strong Financial Performance and Promising Future Prospects Drive Buy Rating - TipRanks
Will Personalis' Testing Growth And MRD Strategy Pay Off In 2025? - Nasdaq
Analyst Expectations For Personalis's Future - Benzinga
Personalis, Inc. (NASDAQ:PSNL) Q1 2025 Earnings Call Transcript - Insider Monkey
Personalis (PSNL) Receives Price Target Boost from Analyst | PSNL Stock News - GuruFocus
H.C. Wainwright Increases Price Target for Personalis (PSNL) to $9 | PSNL Stock News - GuruFocus
Personalis Reports Strong Q1 Growth in Genomics - TipRanks
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Earnings call transcript: Personalis beats Q1 2025 earnings, stock rises By Investing.com - Investing.com South Africa
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong R - GuruFocus
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
Personalis Reports First Quarter 2025 Financial Results - BioSpace
Personalis: Q1 Earnings Snapshot - CTPost
Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Molecular Tests - GuruFocus
Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Mol - GuruFocus
Earnings call transcript: Personalis beats Q1 2025 earnings, stock rises - Investing.com
Personalis (PSNL) Reports Strong Q1 Revenue and Testing Growth | - GuruFocus
Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Esti - GuruFocus
Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Estimate, Revenue at $13.6M Misses Estimate - GuruFocus
Finanzdaten der Personalis Inc-Aktie (PSNL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):